ClinicalTrials.govpublic full text
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
carcinoma, hepatocellular, liver cell carcinoma, liver-directed therapy, tislelizumab, hepatocellular carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913984
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.